Fibroblast Growth Factor 23 (FGF 23) and intact parathyroid hormone (iPTH) as markers of mineral bone disease among Nigerians with non-diabetic kidney disease

BACKGROUND: Excess cardiovascular burden in patients with chronic kidney disease (CKD) has been attributed to the occurrence of CKD-Mineral Bone Disease (CKD – MBD). This study aimed to determine the spectrum of CKD-MBD among Nigerians with CKD using Fibroblast Growth Factor 23 (FGF 23) and intact P...

Descripción completa

Detalles Bibliográficos
Autores principales: Raji, Yemi R, Ajayi, Samuel O, Adeoye, Abiodun M, Amodu, Olukemi, Tayo, Bamidele O, Salako, Babatunde L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Makerere Medical School 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382529/
https://www.ncbi.nlm.nih.gov/pubmed/36032486
http://dx.doi.org/10.4314/ahs.v22i1.42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382529/
https://www.ncbi.nlm.nih.gov/pubmed/36032486
http://dx.doi.org/10.4314/ahs.v22i1.42

Ejemplares similares